Chapter 3 Market and Technology Background
- Osteoarthritis
- Etiology
- Epidemiology and Market Burden
- Prevalence of Osteoarthritis
- Disease Symptoms
- Risk Factors
- Diagnosis
- Treatments
- Reducing the Risk of Osteoarthritis
Chapter 4 Market Dynamics
- Market Drivers
- Increasing Prevalence of Knee Osteoarthritis
- Growing Elderly Population
- Emerging Countries
- Minimally Invasive Procedures
- Market Restraints
- Substitute Treatment Options
- Intellectual Property
- Insurance Denials
- Government Regulations
- Market Opportunities
- Patient Preference
- Strategic Initiatives
- New Product Launches and R&D
Chapter 5 Market Breakdown by Procedure Type
- Global Market for Viscosupplementation by Procedure Type
- Three-Injection Cycle
- Market Size and Forecast
- Single-Injection Cycle
- Market Size and Forecast
- Five-Injection Cycle
- Market Size and Forecast
Chapter 6 Market Breakdown by Application
- Global Market for Viscosupplementation by Application
- Knee Osteoarthritis
- Market Size and Forecast
- Hip Osteoarthritis
- Market Size and Forecast
- Other Applications (Shoulder and Ankle Osteoarthritis)
- Market Size and Forecast
Chapter 7 Market Breakdown by Region
- Global Market for Viscosupplementation by Region
- North America
- United States
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Latin America
- Market Size and Forecast
- Market Analysis
- Middle East and Africa
- Market Size and Forecast
- Market Analysis
Chapter 8 Regulatory Structure: Medical Devices
- Regulatory Background
- Regulation of Medical Devices by Country/Region
- U.S.
- European Union (EU)
- Japan
Chapter 9 Competitive Landscape
- Global Company Market Share Analysis
- Mergers and Acquisitions
- Agreements, Contracts, Collaborations and Partnerships
- New Product Launches
Chapter 10 Company Profiles
- Major Viscosupplement Manufacturers
- Anika Therapeutics Inc.
- Bioventus
- Chugai Pharmaceutical Co., Ltd.
- Ferring B.V.
- Fidia Farmaceutici S.P.A.
- Sanofi
- Seikagaku Corp.
- Other Prominent Companies
List of Tables
Summary Table A: Global Market for Viscosupplementation, by Procedure Type, Through 2025
Summary Table B: Global Market for Viscosupplementation, by Application, Through 2025
Table 1: Global Prevalence of Osteoarthritis (Symptomatic), by Region/Country, Through 2018
Table 2: Prevalence of Obesity in Males and Females in Australia, 1995-2015
Table 3: Global Market for Viscosupplementation, by Procedure Type, Through 2025
Table 4: Global Market for Three-Injection Cycle Viscosupplementation, by Region, Through 2025
Table 5: Global Market for Single-Injection Cycle Viscosupplementation, by Region, Through 2025
Table 6: Global Market for Five-Injection Cycle Viscosupplementation, by Region, Through 2025
Table 7: Global Market for Viscosupplementation, by Application, Through 2025
Table 8: Global Market for Knee Osteoarthritis Viscosupplementation, by Region, Through 2025
Table 9: Global Market for Hip Osteoarthritis Viscosupplementation, by Region, Through 2025
Table 10: Global Market for Other Applications in Viscosupplementation, by Region, Through 2025
Table 11: Global Market for Viscosupplementation, by Region, Through 2025
Table 12: North American Market for Viscosupplementation, by Procedure Type, Through 2025
Table 13: North American Market for Viscosupplementation, by Country, Through 2025
Table 14: European Market for Viscosupplementation, by Sub-Region, Through 2025
Table 15: European Market for Viscosupplementation, by Procedure Type, Through 2025
Table 16: Western European Market for Viscosupplementation, by Country, Through 2025
Table 17: Asia-Pacific Market for Viscosupplementation, by Procedure Type, Through 2025
Table 18: Asia-Pacific Market for Viscosupplementation, by Country, Through 2025
Table 19: Latin American Market for Viscosupplementation, by Procedure Type, Through 2025
Table 20: Middle Eastern and African Market for Viscosupplementation, by Procedure Type, Through 2025
Table 21: Regulatory Approval: U.S. versus Europe
Table 22: Global Market Analysis of Viscosupplements, by Company, 2018
Table 23: Recent Product Launches: Viscosupplementation Market, 2016-2019
Table 24: Recent Product Approvals in the Viscosupplementation Market, 2015-2020
Table 25: Anika Therapeutics Inc.: Revenue, 2016-2018
Table 26: Anika Therapeutics Inc.: Viscosupplement Products, 2018
Table 27: Bioventus: Viscosupplement Products, 2018
Table 28: Chugai Pharmaceutical Co., Ltd.: Revenue, 2016-2018
Table 29: Chugai Pharmaceutical Co., Ltd.: Viscosupplement Products, 2018
Table 30: Ferring B.V.: Revenue, 2016-2018
Table 31: Ferring B.V.: Viscosupplement Products, 2018
Table 32: Fidia Farmaceutici S.p.A.: Viscosupplement Products, 2018
Table 33: Sanofi: Revenue, 2016-2018
Table 34: Sanofi: Viscosupplement Products, 2018
Table 35: Seikagaku Corp.: Revenue, 2016-2018
Table 36: Seikagaku Corp.: Viscosupplement Products, 2018
Table 37: Other Prominent Companies in the Viscosupplementation Market
Table 38: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market Shares for Viscosupplementation, by Procedure Type, 2018
Summary Figure B: Global Market Shares for Viscosupplementation, by Application, 2018
Figure 1: Prevalence of Adult Obesity in Selected Countries, 2016
Figure 2: Global Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 3: Global Market for Three-Injection Cycle Viscosupplementation, 2017-2025
Figure 4: Global Market for Three-Injection Cycle Viscosupplementation, by Region, 2017-2025
Figure 5: Global Market for Single-Injection Cycle Viscosupplementation, 2017-2025
Figure 6: Global Market for Single-Injection Cycle Viscosupplementation, by Region, 2017-2025
Figure 7: Global Market for Five-Injection Cycle Viscosupplementation, 2017-2025
Figure 8: Global Market for Five-Injection Cycle Viscosupplementation, by Region, 2017-2025
Figure 9: Global Market Shares for Viscosupplementation, by Application, 2018
Figure 10: Global Market for Knee Osteoarthritis Viscosupplementation, 2017-2025
Figure 11: Global Market for Knee Osteoarthritis Viscosupplementation, by Region, 2017-2025
Figure 12: Global Market for Hip Osteoarthritis Viscosupplementation, 2017-2025
Figure 13: Global Market for Hip Osteoarthritis Viscosupplementation, by Region, 2017-2025
Figure 14: Global Market for Other Applications in Viscosupplementation, 2017-2025
Figure 15: Global Market for Other Applications in Viscosupplementation, by Region, 2017-2025
Figure 16: Global Market Shares for Viscosupplementation, by Region, 2018
Figure 17: North American Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 18: North American Market Shares for Viscosupplementation, by Country, 2018
Figure 19: U.S. Market for Viscosupplementation, 2017-2025
Figure 20: Canadian Market for Viscosupplementation, 2017-2025
Figure 21: European Market Shares for Viscosupplementation, by Region, 2018
Figure 22: European Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 23: Western European Market Shares for Viscosupplementation, by Country, 2018
Figure 24: UK Market for Viscosupplementation, 2017-2025
Figure 25: German Market for Viscosupplementation, 2017-2025
Figure 26: French Market for Viscosupplementation, 2017-2025
Figure 27: Italian Market for Viscosupplementation, 2017-2025
Figure 28: Spanish Market for Viscosupplementation, 2017-2025
Figure 29: Rest of Western European Market for Viscosupplementation, 2017-2025
Figure 30: Eastern European Market for Viscosupplementation, 2017-2025
Figure 31: Asia-Pacific Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 32: Asia-Pacific Market Shares for Viscosupplementation, by Country, 2018
Figure 33: Japanese Market for Viscosupplementation, 2017-2025
Figure 34: Chinese Market for Viscosupplementation, 2017-2025
Figure 35: Indian Market for Viscosupplementation, 2017-2025
Figure 36: Australian Market for Viscosupplementation, 2017-2025
Figure 37: South Korean Market for Viscosupplementation, 2017-2025
Figure 38: Rest of Asia-Pacific Market for Viscosupplementation, 2017-2025
Figure 39: Latin American Market for Viscosupplementation, 2017-2025
Figure 40: Latin American Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 41: Middle Eastern and African Market for Viscosupplementation, 2017-2025
Figure 42: Middle Eastern and African Market Shares for Viscosupplementation, by Procedure Type, 2018
Figure 43: Global Market Shares for Viscosupplementation, by Major Manufacturer, 2018
Figure 44: Anika Therapeutics Inc.: Revenue Share, by Region, 2018
Figure 45: Anika Therapeutics Inc.: Revenue Share, by Business Segment, 2018
Figure 46: Anika Therapeutics Inc.: Orthobiologics Segment Sales Revenue, 2015-2018
Figure 47: Anika Therapeutics Inc.: R&D Expenditures, 2015-2018
Figure 48: Chugai Pharmaceutical Co., Ltd.: Revenue Share, by Region, 2018
Figure 49: Chugai Pharmaceutical Co., Ltd.: Revenue Share, by Business Segment, 2018
Figure 50: Chugai Pharmaceutical Co., Ltd.: Sales Revenue from Suvenyl, 2015-2018
Figure 51: Chugai Pharmaceutical Co., Ltd.: R&D Expenditures, 2015-2018
Figure 52: Ferring B.V.: Revenue Share, by Region, 2018
Figure 53: Ferring B.V.: R&D Expenditures, 2017 and 2018
Figure 54: Sanofi: Revenue Share, by Region, 2018
Figure 55: Sanofi: Revenue Share, by Business Segment, 2018
Figure 56: Sanofi: Sales Revenue from Synvisc/Synvisc-One, 2015-2018
Figure 57: Sanofi: R&D Expenditures, 2015-2018
Figure 58: Seikagaku Corp.: Revenue Share, by Region, 2018
Figure 59: Seikagaku Corp.: Revenue Share, by Business Segment, 2018
Figure 60: Seikagaku Corp.: Sales Revenue from Gel-One, Visco-3, and Supartz, 2015-2018
Figure 61: Seikagaku Corp.: R&D Expenditures, 2015-2018